Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00394004 · ClinicalTrials.gov registry record

Decision-Making of Hispanics and African-Americans With HIV/AIDS Participating in Clinical Trials

A clinical trial, sponsored by National Institutes of Health Clinical Center (CC).

Completed
Registry status
35
Enrollment target

NCT00394004: Completed study, sponsored by National Institutes of Health Clinical Center (CC).

NCT00394004 is a clinical trial that has completed, run by National Institutes of Health Clinical Center (CC). The registered enrollment target is 35 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00394004 has completed, sponsored by National Institutes of Health Clinical Center (CC).

COMPLETED
Registry status
35 participants
Enrollment target

Study Summary

This study will use focus groups and in-depth individual interviews to explore factors that influence the decision of Hispanics and African-Americans with HIV/AIDS to participate in a research study. HIV-positive Hispanic and African-American patients 18 years of age and older who are enrolled in an NIH HIV/AIDS protocol may be eligible for Part 1, Part 2, or both parts of this study, as follows: Part 1 - Focus group Focus group participants of from six to ten people are interviewed together during a one-time, 2-hour tape-recorded session to explore how they arrived at their decision to enroll in a research study. The group discussion is led by a moderator and a facilitator. Before the session begins, participants complete questionnaires that include information about their age, race, ethnicity, education and social support. Hispanic participants also complete a questionnaire about language preference. At the end of the focus group, participants are offered to be interviewed individually, as described below. Part 2 - In-depth interview An investigator conducts a one-on-one in-depth interview with the participant while a second person observes and tape records the interview. The interview may take from 1 1/2 to 2 hours to complete. Participants who were not in a focus group are asked to complete questionnaires as described in Part 1 above.

Trial Details

FieldValue
Enrollment Target 35 participants
Start Date 2006-10-26
Est. Completion 2011-04-26

What the finished NCT00394004 record still lists

NCT00394004 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 35 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT00394004 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00394004 about?

NCT00394004 is a clinical study titled "Decision-Making of Hispanics and African-Americans With HIV/AIDS Participating in Clinical Trials". This study will use focus groups and in-depth individual interviews to explore factors that influence the decision of Hispanics and African-Americans with HIV/AIDS to participate in a research study. HIV-positive Hispanic and African-American patients 18 years of age and older who are enrolled in a...

What is the current status of trial NCT00394004?

This trial is currently completed. The enrollment target is 35 participants. The study started on 2006-10-26. Estimated completion is 2011-04-26.

Who is sponsoring clinical trial NCT00394004?

This trial is sponsored by National Institutes of Health Clinical Center (CC), which has 338 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01697371 · 35 participants · NA

    Proton Therapy in the Treatment of Liver Metastases

  • NCT01940757 · 35 participants · Phase 1

    Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae

  • NCT02235857 · 35 participants · NA

    Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children

  • NCT02637934 · 35 participants · Phase 1

    Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT00394004, the US trial registry maintained by the National Library of Medicine. NCT00394004 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.